Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:772507rdf:typepubmed:Citationlld:pubmed
pubmed-article:772507lifeskim:mentionsumls-concept:C0302592lld:lifeskim
pubmed-article:772507lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:772507lifeskim:mentionsumls-concept:C0003342lld:lifeskim
pubmed-article:772507lifeskim:mentionsumls-concept:C0019340lld:lifeskim
pubmed-article:772507pubmed:issue5lld:pubmed
pubmed-article:772507pubmed:dateCreated1976-7-6lld:pubmed
pubmed-article:772507pubmed:abstractTextExfoliated cells from the cervices of 22 patients with histologically diagnosed squamous cell carcinoma of the cervix and from those of 24 control women were examined for herpes subtype 2 (HT-2) antigens by indirect immunofluorescence studies. This method demonstrated that cells from all the patients with carcinoma contained antigens related to HT-2 virus. In contrast, squamous cells from the cervices of 24 control women with no cervical disease and of 2 women with chronic cervicitis did not contain such HT-2 antigens. Although an etiologic role of HT-2 virus infection cannot yet be established, it is probable that such infection precedes neoplastic changes.lld:pubmed
pubmed-article:772507pubmed:languageenglld:pubmed
pubmed-article:772507pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:772507pubmed:citationSubsetAIMlld:pubmed
pubmed-article:772507pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:772507pubmed:statusMEDLINElld:pubmed
pubmed-article:772507pubmed:monthMaylld:pubmed
pubmed-article:772507pubmed:issn0029-7844lld:pubmed
pubmed-article:772507pubmed:authorpubmed-author:OsunkoyaB OBOlld:pubmed
pubmed-article:772507pubmed:authorpubmed-author:FabiyiAAlld:pubmed
pubmed-article:772507pubmed:authorpubmed-author:AdelusiBBlld:pubmed
pubmed-article:772507pubmed:issnTypePrintlld:pubmed
pubmed-article:772507pubmed:volume47lld:pubmed
pubmed-article:772507pubmed:ownerNLMlld:pubmed
pubmed-article:772507pubmed:authorsCompleteYlld:pubmed
pubmed-article:772507pubmed:pagination545-8lld:pubmed
pubmed-article:772507pubmed:dateRevised2009-10-26lld:pubmed
pubmed-article:772507pubmed:meshHeadingpubmed-meshheading:772507-H...lld:pubmed
pubmed-article:772507pubmed:meshHeadingpubmed-meshheading:772507-C...lld:pubmed
pubmed-article:772507pubmed:meshHeadingpubmed-meshheading:772507-F...lld:pubmed
pubmed-article:772507pubmed:meshHeadingpubmed-meshheading:772507-U...lld:pubmed
pubmed-article:772507pubmed:meshHeadingpubmed-meshheading:772507-A...lld:pubmed
pubmed-article:772507pubmed:meshHeadingpubmed-meshheading:772507-M...lld:pubmed
pubmed-article:772507pubmed:meshHeadingpubmed-meshheading:772507-H...lld:pubmed
pubmed-article:772507pubmed:meshHeadingpubmed-meshheading:772507-F...lld:pubmed
pubmed-article:772507pubmed:meshHeadingpubmed-meshheading:772507-A...lld:pubmed
pubmed-article:772507pubmed:year1976lld:pubmed
pubmed-article:772507pubmed:articleTitleHerpes type-2 virus antigens in human cervical carcinoma.lld:pubmed
pubmed-article:772507pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:772507lld:pubmed